Comparison between BIOCON IPO and DATAMATICS TECHNOLOGIES IPO.
BIOCON IPO is a Mainboard Bookbuilding IPO proposed to list at NSE, BSE while DATAMATICS TECHNOLOGIES IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of BIOCON IPO is up to ₹315.00 Cr whereas the issue size of the DATAMATICS TECHNOLOGIES IPO is up to ₹113.30 Cr. The final issue price of BIOCON IPO is ₹315.00 per share and of DATAMATICS TECHNOLOGIES IPO is ₹110.00 per share.
| BIOCON IPO | DATAMATICS TECHNOLOGIES IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹5 per share |
| Issue Price (Lower) | ₹270.00 per share | ₹101.00 per share |
| Issue Price (Upper) | ₹315.00 per share | ₹110.00 per share |
| Issue Price (Final) | ₹315.00 per share | ₹110.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 1,00,00,000 shares | 85,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹315.00 Cr | up to ₹93.50 Cr |
| OFS Issue Size | 0 shares | 18,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹19.80 Cr |
| Issue Size Total | 1,00,00,000 shares | 1,03,00,000 shares |
| Issue Size Total (Amount) | up to ₹315.00 Cr | up to ₹113.30 Cr |
BIOCON IPO opens on Mar 11, 2004, while DATAMATICS TECHNOLOGIES IPO opens on Apr 12, 2004. The closing date of BIOCON IPO and DATAMATICS TECHNOLOGIES IPO is Mar 18, 2004, and Apr 19, 2004, respectively.
BIOCON IPO P/E ratio is 80.29, as compared to DATAMATICS TECHNOLOGIES IPO P/E ratio of 22.71.
| BIOCON IPO | DATAMATICS TECHNOLOGIES IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 68.38 | 92.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.53 | 68.95 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 80.29 | 22.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3150.00 Cr. | ₹446.30 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹3.92 | ₹4.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.9 | 24.88 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the BIOCON IPO Retail Individual Investors (RII) are offered 25,00,000 shares while in DATAMATICS TECHNOLOGIES IPO retail investors are offered 25,00,000 shares. Qualified Institutional Buyers (QIB) are offered 60,00,000 shares in BIOCON IPO and 50,75,000 shares in DATAMATICS TECHNOLOGIES IPO.
| BIOCON IPO | DATAMATICS TECHNOLOGIES IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 60,00,000 shares | 50,75,000 shares |
| NII | 15,00,000 shares | 25,37,500 shares |
| RII | 25,00,000 shares | 25,37,500 shares |
| Employee | 0 shares | 1,50,000 shares |
| Others | ||
| Total | 1,00,00,000 shares | 1,03,00,000 shares |
BIOCON IPO subscribed in total, whereas DATAMATICS TECHNOLOGIES IPO subscribed .
